PRNewsWire
01 Apr 2026, 12:50 UTC · 24w ago
Verdict
Headline takes no side. We score ANIX +1.00 — strongly bullish.
+1.00strongly bullish
More positive than 98% of ticker scores this week
Which stocks this story touches
More positive than 98% of ticker scores this week
The company reported positive Phase 1 results for its breast cancer vaccine and is advancing to Phase 2.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Business Wire
9h ago
+5.4%
Price agrees with the score
$2.72 vs $2.58 close before publication (Mar 31) · not market-adjusted
ANIX chart →
